AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 3rd, 2021 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations
WHEREAS, the parties desire to amend the Asset Purchase Agreement dated January 24, 2018 between Biogen MA Inc. and Karyopharm Therapeutics Inc. (the "Agreement") to address rights as to potential new inventions that may arise out of the manufacturing process in connection with the parties' manufacturing activities as set out below.
